FDA Inspection 1264100 — Gulf Coast Regional Blood Center
The FDA completed an inspection of Gulf Coast Regional Blood Center on Feb 28, 2025 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 28, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Houston, TX (United States)